MedTrace Logo

Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)

NCT00000566 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2016-04-15

No results posted yet for this study

Summary

To evaluate the sensitivity and specificity of two major, widely used technologies, radionuclear imaging (ventilation-perfusion scanning) and pulmonary angiography, for the diagnosis of pulmonary embolism.

Conditions

Interventions

PROCEDURE

ventilation-perfusion ratio

PROCEDURE

angiography

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Abass Alavi · University of Pennsylvania

  • Richard Greenspan · Yale University

  • Charles Hales · Massachusetts General Hospital

  • Herbert Saltzman · Duke University

  • Paul Stein · Henry Ford Hospital

  • John Weg · University of Michigan

Study Design

Purpose
DIAGNOSTIC

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1983-09-30
Completion
1989-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000566 on ClinicalTrials.gov